SVRASavara Inc.

$4.21+18% 1Y

$4.21

$3.6152 weeks$6.94

The financials

Savara Inc. by the numbers

Savara Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statement	Q2 2026	Q2 2025	Change
Operating income	−$41M	−$31M	n/a
Net income	−$40M	−$30M	n/a
Diluted EPS	−$0.16	−$0.14	n/a

On our screens:Most shorted stocks

Biotechnology

Ranks #100 of 194 by RyuScore

Alto Neuroscience, Inc.

Aktis Oncology, Inc.

Kura Oncology, Inc.

MeiraGTx Holdings plc